Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    5%
    Check dated 2025-10-06T04:25:00.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a new version (v3.1.0) and includes a contact/identifier entry, while the old version reference (v3.0.2) is removed.
    Difference
    0.1%
    Check dated 2025-09-28T23:42:31.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2 and removed the 'Back to Top' control.
    Difference
    0.3%
    Check dated 2025-09-14T18:42:44.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.3%
    Check dated 2025-09-07T13:05:25.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name, location details, and specific drug information for Fruquintinib, HMPL-013, and sintilimab, while removing extensive disease categories and previous location terms.
    Difference
    3%
    Check dated 2025-08-31T03:45:29.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T20:27:52.000Z thumbnail image

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.